Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Green Island Pharmaceutical is a comprehensive pharmaceutical enterprise based in Haikou, China, specializing in the development, production, and sale of various medicinal products. The company's portfolio includes a wide range of chemical generics and Traditional Chinese Medicine (TCM) formulations, with a particular focus on cardiovascular, anti-infective, and respiratory therapeutic areas. Operating from a modern, GMP-certified manufacturing base, the company produces multiple dosage forms such as capsules, tablets, and granules. Hainan Green Island is well-regarded for its Green Island brand and maintains a robust distribution network across the Chinese domestic market. Its commitment to quality and innovation has established it as a significant player in the regional healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Green Island Pharmaceutical.